The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.105.10.760

We have demonstrated the application of a clinical psychiatric rating scale to a specific problem, namely the evaluation of the effects of lobotomy upon schizophrenia. Our primary concern was the presentation of a technique and tool which assist the clinical psychiatrist to determine with greater accuracy the quantity as well as the quality of the changes occurring in the course of disease and as a result of therapy. We recognize that in this study a relatively small number of patients were involved. If, however, we ourselves and other workers elsewhere carry on with this endeavor we feel that we shall arrive at a better understanding of the psychopathology of schizophrenia and what we may hope for as a result of our treatment methods. We believe the rating scale can aid in this direction because of the following advantages:

1. The patient is rated in terms of his own premorbid personality rather than in comparison with a theoretical average normal or average schizophrenic.

2. It permits of a more accurate definition of the manifestations of the disease process by indicating the quantity and direction of the disturbances occurring in particular functions.

3. It enables us to evaluate the effects of a given method of therapy in 2 different, but highly important areas: (a) upon symptoms produced by the disease itself, and (b) upon personality functions not necessarily involved in the disease process.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.